United States · FDA National Drug Code directory

Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 65862-497_e45a9953-97a0-4885-acbd-5af0f22c4f74
Product NDC: 65862-497
Form: TABLET, FILM COATED
Composition / generic term: Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate
Labeler: Aurobindo Pharma Limited
Marketing category: ANDA
Marketing start / end (source format): 20210330
Source listing expiry: 20261231

Source-listed ingredients

EFAVIRENZ — 600 mg/1
EMTRICITABINE — 200 mg/1
TENOFOVIR DISOPROXIL FUMARATE — 300 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 TABLET, FILM COATED in 1 BOTTLE (65862-497-30) · 65862-497-30

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →